Year: 2005
Type: article
Study design: Observational Study
Abstract: We conducted prospective surveillance of childhood hemolytic uremic syndrome (HUS) from 1997 to 2001 to describe disease incidence and clinical, epidemiologic and microbiologic characteristics.We compared our findings, where possible, with those of a previous study conducted from 1985 to 1988.The average annual incidence of HUS for the United Kingdom and Ireland (0.71/100,000) was unchanged from 1985 to 1988.The overall early mortality had halved, but the reduction in mortality was almost entirely accounted for by improved outcome in patients with diarrhea-associated HUS.The principal infective cause of diarrhea-associated HUS was Shiga toxin-producing Escherichia coli O157 (STEC O157), although in the 1997-2001 survey STEC O157 phage type (PT) 21/28 had replaced STEC O157 PT2 as the predominant PT.The risk of developing diarrhea-associated HUS was significantly higher in children infected with STEC O157 PT 2 and PT 21/28 compared with other PTs.Hypertension as a complication of HUS was greatly reduced in patients with diarrhea-associated HUS.T he most serious manifestation of infection with Shiga toxin-producing Escherichia coli (STEC) in humans is hemolytic uremic syndrome (HUS).This syndrome comprises a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure, usually after a prodromal illness of acute gastroenteritis (1).At least 80% of childhood HUS is attributable to infection with STEC (2), mainly serogroup O157, although other serogroups are implicated (2-10).The peak incidence of HUS is in children <5 years of age (1).Surveillance of pediatric HUS provides valuable information on human infection with STEC.In a prospective survey of pediatric HUS from 1985 to 1988 in the British Isles, the average annual incidence was ≈0.79 per 100,000 children <16 years of age (3).In the intervening years, the number of laboratory-confirmed cases of STEC O157 in England and Wales increased from 50 in 1985 (11) to 1,087 in 1997 (12).Similar increases were seen in Scotland and Ireland (Figure).Some of the increase in STEC O157 might reflect improved laboratory techniques, improved detection or reporting of milder cases, and a greater awareness of the need to investigate diarrheal disease for STEC.If the increase in STEC O157 was real, however, then the incidence of childhood HUS should have also increased.Therefore, we conducted prospective surveillance of childhood HUS in the United Kingdom and Ireland from 1997 to 2001 to describe the impact of disease and clinical, epidemiologic, and microbiologic characteristics of the patients.We also compared our findings, where possible, with those of a previous study (3,4). Patients and Methods Definition of HUSHUS was defined as 1) acute renal failure, including oligoanuria and elevated creatinine level for age, 2) microangiopathic hemolytic anemia (hemoglobin level <10 g/L with fragmented erythrocytes), and 3) thrombocy- Childhood Hemolytic Uremic Syndrome, United Kingdom and Ireland
Source: Emerging infectious diseases
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: diamond
OpenAlex ID: W2024243377
